Plamed Group Logo

Recombinant Collagen (Type III) | Humanized Collagen for Skin Repair and Firmness

A humanized recombinant type III collagen with 100% sequence homology to the functional domain of human skin collagen III, a collagen raw material designed for barrier repair, collagen renewal and premium anti-aging formulas.

Recombinant Collagen

Recombinant Collagen

A humanized recombinant collagen protein with 100% sequence homology to human Type III collagen, designed to support skin barrier repair, collagen renewal, and skin rejuvenation.

Plamed combines 100% sequence coverage validation with ultra-low endotoxin control to help preserve collagen bioactivity while meeting high safety standards. It provides a reliable ingredient solution for skin repair formulations and premium anti-aging skincare products.

At a glance

Item

Detail

Product

Recombinant Collagen (recombinant human collagen type III)

Product ID

PMKZ2601

INCI name

SOLUBLE COLLAGEN

Other names

Recombinant type III humanized collagen; humanized collagen III; recombinant collagen iii

CAS number

9007-34-5

Molecular formula

C1969H3088N664O675S4

Molecular weight

47 kDa

Purity

≥90.0% (HPLC)

Content

≥90.0%

Bacterial endotoxin

<0.5 EU/mg

Appearance

White to off-white powder or spongy solid

pH value

4.5–7.0

Solubility

≥100 mg/mL in water

Reference dosage

0.01%–0.2%

Minimal package

10 g bottle

Storage

2–8 °C, sealed, protected from strong light

Product image of Recombinant Collagen (PMKZ2601)

Recombinant Collagen (INCI: SOLUBLE COLLAGEN; CAS 9007-34-5) is a humanized recombinant type III collagen, its amino acid sequence is 100% homologous to the functional domain of natural human skin type III collagen. Plamed produces it by genetic engineering recombination: high-density fermentation, followed by separation and purification, yielding a high-purity, high-activity collagen raw material for cosmetic use.

Where it sits in a formula: recombinant collagen for skin works on the repair-and-rebuild side. It specifically binds integrin receptors on the cell surface and activates cell signaling pathways; it supplements type III collagen lost in the dermis, promotes fibroblast proliferation and migration, and upregulates the gene and protein expression of type I/III collagen and elastin. It also promotes keratinocyte proliferation, migration and adhesion, the cellular basis of barrier repair, and has been shown in vitro to inhibit LPS-induced inflammatory response by downregulating pro-inflammatory factor release.

Why the 47 kDa size is deliberate. Traditional animal-derived collagen is hundreds of kDa and cannot penetrate the stratum corneum; small collagen peptides (<1000 Da) dissolve easily but lose the complete triple-helix activity. Through sequence design, this material keeps complete functional domains at 47 kDa, retaining the cell-adhesion and repair sequences and a stable triple helix, while staying water-soluble (≥100 mg/mL) with skin-penetration potential. It resolves the industry trade-off between transdermal delivery and intact biological activity.

Cosmetic-medicine-grade endotoxin control. An extreme control system for bacterial endotoxin reaches <0.5 EU/mg, far below ordinary cosmetic grade, supporting use in barrier-repair, post-procedure and hypersensitive-skin positioned products.

Dual structural confirmation. Each lot is verified by 100% peptide sequence coverage plus terminal amino acid sequence consistency, confirming the material is the designed humanized type III sequence rather than a mixed hydrolysate, the documentation basis for regulatory filing and efficacy claims in major markets.

Recombinant Collagen Manufacturer | Barrier Repair | Plamed